S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

INO Inovio Pharmaceuticals Inc New

12.20

0.19 (1.58%)

May 03 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Inovio Pharmaceuticals Charts.

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Inovio Pharmaceuticals Charts.

Inovio Pharmaceuticals, Inc. News

INOVIO Reports Inducement Grants Under Inducement Plan
Wednesday 1 May 2024 (5 days ago) • PR Newswire (US)

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
Monday 29 April 2024 (7 days ago) • PR Newswire (US)

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Monday 15 April 2024 (3 weeks ago) • PR Newswire (US)

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
Tuesday 26 March 2024 (1 month ago) • PR Newswire (US)

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Wednesday 6 March 2024 (2 months ago) • PR Newswire (US)

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Wednesday 6 March 2024 (2 months ago) • PR Newswire (US)

U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb
Wednesday 6 March 2024 (2 months ago) • IH Market News

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
Wednesday 21 February 2024 (2 months ago) • PR Newswire (US)

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Wednesday 7 February 2024 (3 months ago) • PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan
Friday 2 February 2024 (3 months ago) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Friday 26 January 2024 (3 months ago) • Edgar (US Regulatory)

More Inovio Pharmaceuticals, Inc. News Articles

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

TheGlobe com (PK)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

Lightwave Logic

Trump Media and Technology

Code Green Apparel (PK)

Anavex Life Sciences

TPT Global Tech (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions